CClinicalTrials.gg
Sign In
Status unknownNCT02283645Updated Dec 2, 2014

Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement

A Phase 4 interventional study of 3 % minoxidil lotion and Placebo in Chest Hair Enhancement, sponsored by Mae Fah Luang University Hospital. Status unknown. Open to male participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-12-02.

Sponsored by Mae Fah Luang University Hospital · Phase 4, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2014), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 4
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Male
01

Study summary

The purpose of this study is to determine efficacy and safety of 3% minoxidil lotion for chest hair enhancement.

02

Conditions studied

  • Chest Hair Enhancement
03

In context

Lead sponsor

Mae Fah Luang University Hospital is the lead sponsor of 13 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy male

Exclusion criteria

Exclusion Criteria:

  • serious underlying diseases
  • history of chest/ hair treatment before 6 months
  • history of surgery or trauma on chest area.
  • history of minoxidil allergy
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Minoxidil

    3% Minoxidil lotion is applied twice daily to the chest.

    Drug: 3 % minoxidil lotion

  • Placebo comparator
    Placebo

    Placebo lotion is applied twice daily to the chest.

    Drug: Placebo

Interventions

  • Drug3 % minoxidil lotion
  • DrugPlacebo
06

What researchers measure

Primary outcomes

  1. The change of global photographic assessment after 20 weeks from baseline

    Time frame: baseline and 20 weeks

Secondary outcomes

  1. The change in number of hairs after 20 weeks from baseline

    Time frame: baseline and 20 weeks

Other outcomes

  1. The change of hair diameter after 20 weeks from baseline

    Time frame: baseline and 20 weeks

  2. Number of participants with adverse events

    Time frame: baseline and 20 weeks

  3. Patient satisfaction by self-assessment questionnaires

    Time frame: baseline and 20 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Lee S, Tanglertsampan C, Tanchotikul M, Worapunpong N. Minoxidil 2% lotion for eyebrow enhancement: a randomized, double-blind, placebo-controlled, spilt-face comparative study. J Dermatol. 2014 Feb;41(2):149-52. doi: 10.1111/1346-8138.12275. Epub 2013 Nov 8. PubMed 24471459 ↗
  • Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10.1111/j.1346-8138.2012.01579.x. Epub 2012 May 17. No abstract available. PubMed 22594928 ↗
  • Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012 Oct;95(10):1312-6. PubMed 23193746 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 2, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02283645
Lead sponsor
Mae Fah Luang University Hospital
Responsible party
Chuchai TANGLERTSAMPAN, MD (Assitant Professor, Mae Fah Luang University Hospital) — Principal investigator
First posted
Nov 5, 2014
Start date
Jan 2015
Primary completion
Aug 2015 (estimated)
Completion
Aug 2015 (estimated)
Last update
Dec 2, 2014

Study contacts

Chuchai Tanglertsampan, MD
Contact
drchuchait@yahoo.com
Sittichai Ingprasert, MD
Contact
sittichai113@hotmail.com

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Mae Fah Luang University Hospital

Start the discussion